Carisma Therapeutics, Inc.
CARM
$0.237
$0.01124.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -49.38M | -50.77M | -60.48M | -63.80M | -72.50M |
| Total Depreciation and Amortization | 2.07M | 2.32M | 3.35M | 3.41M | 3.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 9.45M | 7.94M | 9.16M | 10.60M | 10.63M |
| Change in Net Operating Assets | 518.00K | -7.05M | -11.95M | -17.87M | -17.14M |
| Cash from Operations | -37.34M | -47.56M | -59.92M | -67.66M | -75.64M |
| Capital Expenditure | 0.00 | -106.00K | -123.00K | -684.00K | -873.00K |
| Sale of Property, Plant, and Equipment | 687.00K | 524.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 11.00M | 41.00M |
| Cash from Investing | 687.00K | 418.00K | -123.00K | 10.32M | 40.13M |
| Total Debt Issued | 0.00 | 0.00 | 686.00K | 686.00K | 849.00K |
| Total Debt Repaid | -1.82M | -1.75M | -2.74M | -2.73M | -3.62M |
| Issuance of Common Stock | 134.00K | 136.00K | 2.42M | 3.11M | 3.02M |
| Repurchase of Common Stock | -23.00K | -23.00K | -23.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -758.00K |
| Cash from Financing | -1.71M | -1.63M | 344.00K | 1.07M | -507.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.36M | -48.78M | -59.70M | -56.28M | -36.02M |